Detroit Tigers are backing MLB's top record with a potential 3 position players to start the 2025 All-Star Game, with ...

While Amgen’s monthly obesity candidate MariTide helped patients lose significant amounts of weight in a phase 2 study, ...

Pfizer Inc. (NYSE:PFE) announced encouraging results from its Phase 3 clinical trial of HYMPAVZI, a potential new treatment for patients with hemophilia A or B who develop inhibitors—a major ...

AstraZeneca is currently recruiting participants for a Phase 3 clinical trial titled DESTINY-Biliary Tract Cancer-01, which aims to assess the efficacy and safety of Trastuzumab D ...

A phase 3 clinical trial investigating ST-100 for the treatment of dry eye disease did not meet its primary endpoint but ...

Viking Therapeutics advances its dual GLP-1/GIP obesity drug into Phase 3 trials, entering a $100 billion weight loss market. Applied Digital's $7 billion CoreWeave partnership transforms it into an ...

Eli Lilly isn't a one-trick pony. The company's lineup of approved medicines features blockbusters like Verzenio, a cancer ...

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

Approved eight months ago for a certain class of patients with both hemophilia A or B, Pfizer’s Hympavzi has now shown its effectiveness in another group of patients with the bleeding disorder. | ...

Stuart Therapeutics’ dry eye disease drug has failed to demonstrate that it can increase tear production in a phase 3 test.

The Lahaina Fire Forward-Looking Report (Phase 3) organized the findings from the Lahaina Fire Comprehensive Timeline Report ...

Joint venture's award is part of a nearly $3.3B effort to build a larger lock to accommodate modern cargo vessels as they traverse the 21-ft elevation change traveling between Lake Superior and the ...